Trademark Overview
On Saturday, May 18, 2024, a trademark application was filed for MEDXIST with the United States Patent and Trademark Office. The USPTO has given the MEDXIST trademark a serial number of 98557656. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, May 18, 2024. The MEDXIST trademark is filed in the Pharmaceutical Products category with the following description:
Chondroitin preparations; DHA algae oil dietary supplements; Dietary and nutritional supplements used for weight loss; Dietary supplements for controlling cholesterol; Dietary supplements for human consumption; Ganoderma lucidum spore powder dietary supplements; Herbal male enhancement capsules; Linseed oil dietary supplements; Mineral dietary supplements; Nutraceuticals for use as a dietary supplement; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets